[Corrigendum] Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth

• Authors:
  • Zi-Xue Xuan
  • Lin-Na Li
  • Qi Zhang
  • Cheng-Wang Xu
  • De-Xuan Yang
  • Ye Yuan
  • Ying-Hong An
  • Shan-Shan Wang
  • Xiao-Wen Li
  • Shou-Jun Yuan

• View Affiliations

  
  Affiliations: Department of Pharmacology and Toxicology, Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China, Department of Production Technology, Shandong Buchang Shenzhou Pharmaceutical Co., Ltd., Heze 274000, P.R. China
• Published online on: October 23, 2023     https://doi.org/10.3892/ijo.2023.5583
• Article Number: 135

• Copyright : © Xuan et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Article

View Figures

Figure 1